| abstract |
The invention provides the use of compound of formula V or formula VI in the treatment of a demyelinating peripheral neuropathy: n n n n n n n n n n wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , n, R 1a , R 2a , R 3a , R 4a , R 5a , R 6a , R 7a , X a and n a are defined herein; or the N-oxide derivatives thereof or prodrugs thereof, or a pharmaceutically acceptable salt, solvate or hydrate thereof. The invention further provides combinations of a compound of Formula V or VI with one or more therapeutic agents and pharmaceutical composition thereof. |